These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 7029111)
1. [Insulinemia in patients with hyperlipoproteinemia type IIa and V]. Młyński J Kardiol Pol; 1981; 24(9):605-9. PubMed ID: 7029111 [No Abstract] [Full Text] [Related]
2. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. III. Selected blood serum indicators of carbohydrate metabolism]. Klimek K; Gregorczyk J; Pieczul-Mróz J Przegl Lek; 1983; 40(10):719-25. PubMed ID: 6364255 [No Abstract] [Full Text] [Related]
3. [Insulinemia after oral and intravenous glucose administration in chronic pancreatitis]. Chciuk-Górnicka M; Szadkowski M; Muszyński J Pol Tyg Lek; 1980 Sep; 35(36):1369-71. PubMed ID: 7001408 [No Abstract] [Full Text] [Related]
4. [Dynamics of insulinemia in chronic glomerulonephritis]. Kozhevnikov AD; Bobrov IuF Ter Arkh; 1978; 50(6):68-72. PubMed ID: 675540 [No Abstract] [Full Text] [Related]
5. [Study of phospholipids in primary hyperlipoproteinemias]. Kuczyńska K Pol Arch Med Wewn; 1979 Jul; 62(1):29-40. PubMed ID: 503884 [No Abstract] [Full Text] [Related]
6. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. VIII. Blood insulin and its direct relation to selected parameters of carbohydrate metabolism]. Klimek K; Gregorczyk J; Olejak B; Pieczul-Mróz D; Morawiec-Borowiak D Przegl Lek; 1984; 41(3):265-72. PubMed ID: 6377395 [No Abstract] [Full Text] [Related]
7. [Basal insulinemia, its relation to dyslipoproteinemias and arterial pressure]. Suntsov IuI; Mazovetskiĭ AG; Zhukovskiĭ GS; Polesskiĭ VA; Zadoia AA Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):33-7. PubMed ID: 7046764 [TBL] [Abstract][Full Text] [Related]
9. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs. Hutt V; Wechsler JG; Klör HU; Ditschuneit H Artery; 1980; 8(2):113-9. PubMed ID: 7458676 [TBL] [Abstract][Full Text] [Related]
10. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. V. Evaluation of circulatory hemodynamics based on the measurements of systolic time intervals and the physical analysis of blood circulation]. Olejak B; Szmatłoch E; Brzeźniak R; Gregorczyk J; Pieczul-Mróz J; Jankowska E; Jagła A Przegl Lek; 1983; 40(11):797-801. PubMed ID: 6669732 [No Abstract] [Full Text] [Related]
11. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate. Al-Waili N Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866 [TBL] [Abstract][Full Text] [Related]
12. High density lipoprotein and arteriosclerosis. Different patterns in primary hypothyroidism and type IIa hyperlipoproteinemia. Brook JG; Aviram M; Luboshitzky R; Barzilai D Isr J Med Sci; 1981 May; 17(5):318-22. PubMed ID: 7263188 [TBL] [Abstract][Full Text] [Related]
13. [Hyperlipoprotein phenotypes as risk factors in ischemic cardiopathy. II. Clinical aspects]. Walter-Rosianu A Rev Pediatr Obstet Ginecol Pediatr; 1984; 33(2):145-60. PubMed ID: 6429817 [No Abstract] [Full Text] [Related]
14. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure]. Jovanović D; Djukanović Lj; Veljović R; Manojlović D Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808 [TBL] [Abstract][Full Text] [Related]
15. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration]. Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980 [No Abstract] [Full Text] [Related]
16. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis]. Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981 [TBL] [Abstract][Full Text] [Related]
17. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. VI. Evaluation of arterial elasticity based on the physical analysis of blood circulation]. Szmatłoch E; Olejak B; Gregorczyk J; Pieczul-Mróz J; Jagła A; Kutrzeba J; Cwajda H Przegl Lek; 1983; 40(11):803-6. PubMed ID: 6669733 [No Abstract] [Full Text] [Related]
18. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. IV. Blood coagulation and fibrinolysis indicators]. Borodin M; Jurek D; Gregorczyk J; Pieczul-Mróz J; Cwajda H Przegl Lek; 1983; 40(10):727-32. PubMed ID: 6665208 [No Abstract] [Full Text] [Related]
19. [Relations between the blood insulin response and kalemia during the glucose tolerance test]. Strollo G; Morè M; Di Cesare T; Di Pietro S; Meloncelli I Boll Soc Ital Biol Sper; 1981 Nov; 57(21):2137-43. PubMed ID: 7039639 [No Abstract] [Full Text] [Related]
20. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. Noseda G; Fragiacomo C; Weidmann P; Bachmann C Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]